Aminoglutethimide treatment in advanced breast cancer: An efficient therapy as a late endocrine alternative in a sequential therapeutic approach

[1]  R. Santen.  Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review , 2005, Breast Cancer Research and Treatment.

[2]  A. Harris,et al.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. , 1981, British medical journal.

[3]  R. Santen,et al.  A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. , 1981, The New England journal of medicine.

[4]  J. Bennett,et al.  Treatment of metastatic breast cancer with aminoglutethimide , 1981, Cancer.

[5]  R. Santen,et al.  Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. , 1978, The Journal of clinical endocrinology and metabolism.

[6]  R. Santen,et al.  Pancytopenia induced by aminoglutethimide in the treatment of breast cancer. , 1978, Cancer treatment reports.

[7]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[8]  W. Lawrence,et al.  Medical and surgical adrenalectomy in patients with advanced breast carcinoma , 1977, Cancer.

[9]  H. Randall,et al.  The results of adrenalectomy in advanced breast cancer in 500 consecutive patients. , 1967, Surgery, gynecology & obstetrics.

[10]  P. Satoh,et al.  Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. , 1967, The Journal of clinical endocrinology and metabolism.

[11]  C. Huggins,et al.  Bilateral adrenalectomy in the treatment of cancer of the breast. , 1955, A.M.A. archives of surgery.